Methods and compositions for assessing antibody specificities
AssigneeSerimmune Inc.
InventorsPatrick Sean Daugherty, Kathryn Vinaya Louise Kamath, Jack Ryan Reifert
Life of this patent
Estimating the term…
Abstract
The present invention provides compositions and methods that can be used to determine a peptide signature for an antibody repertoire in a sample comprising multiple antibodies. The method can be used to characterize a phenotype in a sample, such as providing a diagnosis, prognosis or theranosis of a medical condition.
Claims31
1-65. (canceled)
An array comprising an array surface and at least five peptide probes, wherein each of the at least five peptide probes comprises a binding motif selected from the group consisting of:
- [RK]MRxID (SEQ ID NO:
- 104), QHxGHP (SEQ ID NO:
- 105), KxxLPED (SEQ ID NO:
- 106), [IV]LxxFGY (SEQ ID NO:
- 107), PLDxxxxIS (SEQ ID NO:
- 108), ETXIPXE (SEQ ID NO:
- 109), [VI]Nx[DE][ML]YxP (SEQ ID NO:
- 110), FLxxIGA (SEQ ID NO:
- 111), D[VI]x[MI][ILV]x[KR] (SEQ ID NO:
- 112), RxSPYx[IL]F (SEQ ID NO:
- 113), VGPRH (SEQ ID NO:
- 114), PQxQH[ED] (SEQ ID NO:
- 115), PxxGGFG (SEQ ID NO:
- 116), KxEGxxMG (SEQ ID NO:
- 117), KxxGxTxxLS (SEQ ID NO:
- 118), EMG[FW]Q (SEQ ID NO:
- 119), [VI]KxGxxDxP (SEQ ID NO:
- 120), PE[DN]ExYP (SEQ ID NO:
- 121), HYEWA (SEQ ID NO:
- 122), [HR]SNMxF (SEQ ID NO:
- 123), M[TV]GxxYE (SEQ ID NO:
- 124), Dxx[KH]ExxLL (SEQ ID NO:
- 125), RxxWx[EDA]x[IV][AR] (SEQ ID NO:
- 126), PxDxxAx[GPA][TS] (SEQ ID NO:
- 127), PDxxSxT[ARG] (SEQ ID NO:
- 128), GRExDG (SEQ ID NO:
- 129), GVPGxxxK (SEQ ID NO:
- 130), [LM]xxx[EDQ]VxxIM (SEQ ID NO:
- 131), SxxxVSGG (SEQ ID NO:
- 132), A[KR]AG[DN]K (SEQ ID NO:
- 133), F[RN]xIN[RQ] (SEQ ID NO:
- 134), YXPVXPXSY (SEQ ID NO:
- 135), KxTFPD (SEQ ID NO:
- 136), PFM[FVM]xxR (SEQ ID NO:
- 137), EFWEP (SEQ ID NO:
- 138), [FY]GALS (SEQ ID NO:
- 139), PxGTEN (SEQ ID NO:
- 140), Gx[KE]PWE (SEQ ID NO:
- 141), and D[IV]Tx[YF][WN] (SEQ ID NO:
- 142), and wherein the at least five peptide probes extend from the array surface.
The method of claim 21, wherein the binding of the one peptide probe to its target antibody or the no binding of the at least five peptide probes to its target antibody indicates the subject is negative for Trypanosoma cruzi infection.
Dependencies are inferred from the claim text.